 |
 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
SUMMARIES FOR PATIENTS
Very High Doses of Methadone May Cause Abnormal Heart Rhythm
17 September 2002 | Volume 137 Issue 6 | Page I-42
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine.
The summary below is from the full report titled "Torsade de Pointes Associated with Very-High-Dose Methadone." It is in the 17 September 2002 issue of Annals of Internal Medicine (volume 137, pages 501-504). The authors are MJ Krantz, L Lewkowiez, H Hays, MA Woodroffe, AD Robertson, and PS Mehler.
What is the problem and what is known about it so far?
At rest, the heart usually pumps blood at a rate of 60 to 90 beats per minute. Although extra beats occasionally occur, the normal pattern (rhythm) of heartbeats is fairly regular. The heart has an electrical system that runs through the upper heart chambers (atria) and the lower heart chambers (ventricles). The electrical system controls the heart rate and rhythm. Age, diseases, and drugs can affect the electrical system and cause abnormal rhythms (arrhythmia). Some arrhythmias reduce the ability of the heart to pump blood. Some even cause cardiac arrest, a sudden and complete failure of the heart to pump blood. Torsade de pointes is an uncommon but dangerous arrhythmia that causes cardiac arrest. It disrupts the normal electrical system of the lower heart chambers (ventricular arrhythmia). During the past decade, doctors have learned that several different types of drugs can cause torsade de pointes. However, few patients with torsade de pointes due to opioids (drugs such as morphine and methadone) have been described.
Why did the researchers do this particular study?
To describe torsade de pointes in several patients who were taking very high doses of methadone.
Who was studied?
17 adults who were taking very high doses of methadone either for pain control or as part of a drug addiction treatment program.
How was the study done?
Two doctors noticed that a few of their patients who were taking methadone were hospitalized with torsade de pointes. One doctor practiced in a chronic pain clinic, and the other practiced in a methadone treatment program for people with drug addiction. Both doctors knew that torsade de pointes was an uncommon and serious arrhythmia. Although they were experts in using methadone, they had not heard any reports of torsade de pointes due to methadone. When they heard about each other's patients, they decided to report them.
What did the researchers find?
The doctors found 17 patients who were brought to the hospital after passing out. All had heart tracings that showed torsade de pointes. Most were taking very high doses of methadone (about 400 mg daily). Seven had low potassium levels in their blood. Nine were taking other drugs that have been associated with arrhythmias. All patients were treated successfully and survived. Fourteen patients needed insertion of a pacemaker or a machine that provides an electric shock (defibrillator) to get their heart working.
What were the limitations of the study?
This study cannot show with certainty that methadone causes torsade de pointes because several patients had other factors (low potassium level, therapy with other drugs) that could cause arrhythmia. Also, the study does not show the frequency of torsade de pointes in patients taking very high doses of methadone.
What are the implications of the study?
Very high doses of methadone may cause torsade de pointes.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  W. K. Kraft, E. Gibson, K. Dysart, V. S. Damle, J. L. LaRusso, J. S. Greenspan, D. E. Moody, K. Kaltenbach, and M. E. Ehrlich Sublingual Buprenorphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Trial Pediatrics, September 1, 2008; 122(3): e601 - e607. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. LEVINE, S. Z. ROSERO, A. S. BUDZIKOWSKI, A. J. MOSS, W. ZAREBA, and J. P. DAUBERT Congenital long QT syndrome: Considerations for primary care physicians Cleveland Clinic Journal of Medicine, August 1, 2008; 75(8): 591 - 600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. F. Wedam, G. E. Bigelow, R. E. Johnson, P. A. Nuzzo, and M. C. P. Haigney QT-Interval Effects of Methadone, Levomethadyl, and Buprenorphine in a Randomized Trial Arch Intern Med, December 10, 2007; 167(22): 2469 - 2475. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Fanoe, C. Hvidt, P. Ege, and G. B. Jensen Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen Heart, September 1, 2007; 93(9): 1051 - 1055. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Drake, R. Preston, and J. Douglas Brief review: Anesthetic implications of long QT syndrome in pregnancy: [Article de synthese court : Implications anesthesiques du syndrome du QT long pendant la grossesse] Can J Anesth, July 1, 2007; 54(7): 561 - 572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Hadi, P. K. Morley-Forster, S. Dain, K. Horrill, and D. E. Moulin Brief review: Perioperative management of the patient with chronic non-cancer pain: [Article de synthese court : Prise en charge perioperatoire des patients souffrant de douleur chronique non cancereuse] Can J Anesth, December 1, 2006; 53(12): 1190 - 1199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. B. Ehret, D. Shah, P. Dayer, and J. A. Desmeules QTc Prolongation Among Hospitalized Patients Receiving Methadone--Reply Arch Intern Med, November 13, 2006; 166(20): 2289 - 2290. [Full Text] [PDF]
|
|
|
|
|
|
G. B. Ehret, C. Voide, M. Gex-Fabry, J. Chabert, D. Shah, B. Broers, V. Piguet, T. Musset, J.-M. Gaspoz, A. Perrier, et al. Drug-Induced Long QT Syndrome in Injection Drug Users Receiving Methadone: High Frequency in Hospitalized Patients and Risk Factors. Arch Intern Med, June 26, 2006; 166(12): 1280 - 1287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R Baker, A. M Best, P. A Pade, and E. F McCance-Katz Effect of Buprenorphine and Antiretroviral Agents on the QT Interval in Opioid-Dependent Patients Ann. Pharmacother., March 1, 2006; 40(3): 392 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rademacher, R. Dietz, and W. Haverkamp QT prolongation and syncope with methadone, doxepin, and a {beta}-blocker Ann. Pharmacother., October 1, 2005; 39(10): 1762 - 1763. [Full Text] [PDF]
|
|
|
|
|
|
P. W. H. Peng, P. S. Tumber, and D. Gourlay Review article: Perioperative pain management of patients on methadone therapy: [Expose de synthese : Traitement de la douleur perioperatoire chez les patients sous therapie a la methadone] Can J Anesth, May 1, 2005; 52(5): 513 - 523. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Berdine and M. G. Mihalyo Demographics, Pharmacoeconomics, Assessment, and Treatment of Pain in the Elderly Journal of Pharmacy Practice, April 1, 2004; 17(2): 115 - 128. [Abstract] [PDF]
|
|
|
|
|
|
M. J. Krantz and P. S. Mehler Treating Opioid Dependence: Growing Implications for Primary Care Arch Intern Med, February 9, 2004; 164(3): 277 - 288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Krantz, B. A. Martell, J. H. Arnsten, and M. N. Gourevitch Medications That Prolong the QT Interval JAMA, August 27, 2003; 290(8): 1025 - 1025. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sala, I. Anguera, and M. Cervantes Torsade de Pointes Due to Methadone Ann Intern Med, August 19, 2003; 139(4): W-64 - W-64. [Full Text] [PDF]
|
|
|
|
|
|
E. O. Mokwe and O. Ositadinma Torsade de Pointes Due to Methadone Ann Intern Med, August 19, 2003; 139(4): W-64 - W-64. [Full Text] [PDF]
|
|
|
|
|
|
B. A. Martell, J. H. Arnsten, B. Ray, and M. N. Gourevitch The Impact of Methadone Induction on Cardiac Conduction in Opiate Users Ann Intern Med, July 15, 2003; 139(2): 154 - 155. [Full Text] [PDF]
|
|
|
|
|
|
D. De Bels, M. Staroukine, and J. Devriendt Torsades de Pointes Due to Methadone Ann Intern Med, July 15, 2003; 139(2): W-58 - W-58. [Full Text] [PDF]
|
|
|
|
|
|
M. J. Krantz and P. S. Mehler Synthetic Opioids and QT Prolongation Arch Intern Med, July 14, 2003; 163(13): 1615 - 1615. [Full Text] [PDF]
|
|
|
|
|
|
N. Goldschlager and A. E. Epstein Synthetic Opioids and QT Prolongation--Reply Arch Intern Med, July 14, 2003; 163(13): 1615 - 1615. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
